Julie Ren, Ph.D. Co-Founder & Head of BA and Preclinical Development
Julie has over 19 years of industry experience in drug discovery and development, most recently as Director, Bioanalytical, Nonclinical Development (DMPK) at Exelixis. Julie led the discovery bioanalysis and pharmacokinetics, conducting and managing pharmacokinetics, toxicokinetics, PK/PD, PK/efficacy, drug distribution, metabolite identification, and cellular uptake evaluations for lead validation and optimization at Exelixis. She also established and managed the GLP bioanalytical laboratory in supporting non-clinical toxicokinetics, clinical pharmacokinectics, metabolism, drug-drug interaction and bioequivalence studies for over twenty IND and one NDA filings. Julie has participated in multiple successful FDA audits. Julie obtained her Ph.D. from University of Alabama and did post-doctoral research at University of California, San Francisco.